ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

ClinicalTrials.gov ID: NCT06108219

Public ClinicalTrials.gov record NCT06108219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Study identification

NCT ID
NCT06108219
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Corcept Therapeutics
Industry
Enrollment
175 participants

Conditions and interventions

Interventions

  • Miricorilant (Cohort A) Drug
  • Miricorilant (Cohort B) Drug
  • Placebo (Cohort A) Drug
  • Placebo (Cohort B) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2023
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026
Last update posted
Apr 20, 2026

2023 – 2026

United States locations

U.S. sites
48
U.S. states
16
U.S. cities
44
Facility City State ZIP Site status
Site #207 Chandler Arizona 85224
Site #209 Tucson Arizona 85712
Site #378 Huntington Park California 90255
Site #439 Lancaster California 93534
Site #469 Long Beach California 90815
Site #373 Los Angeles California 90056
Site #214 Panorama City California 91402
Site #233 Santa Ana California 92704
Site #452 Boca Raton Florida 33434
Site # 101 Gainesville Florida 32610
Site #465 Hallandale Florida 33009
Site #430 Hialeah Gardens Florida 33016
Site #458 Lakewood Rch Florida 38018
Site #475 Largo Florida 33777
Site #438 Miami Lakes Florida 33016
Site #460 Viera Florida 32940
Site #453 Houma Louisiana 70363
Site #451 Marrero Louisiana 70072
Site #061 Metairie Louisiana 70006
Site #440 Rockville Maryland 20854
Site #442 Saint Paul Minnesota 55114
Site #228 Kansas City Missouri 64131
Site #455 Jackson New Jersey 08724
Site #445 East Syracuse New York 13057
Site #454 New York New York 10033
Site #464 Morehead City North Carolina 29557
Site #447 Beavercreek Ohio 45440
Site #470 Columbus Ohio 43234
Site #448 Dayton Ohio 45145
Site #437 Westlake Ohio 44145
Site #461 Cordova Tennessee 38018
Site # 546 Arlington Texas 76012
Site #545 Austin Texas 78756
Site #211 Austin Texas 78757
Site #432 Brownsville Texas 78520
Site #370 Dallas Texas 75230
Site #213 Edinburg Texas 78539
Site #215 Edinburg Texas 78539
Site #431 Georgetown Texas 78626
Site # 066 Houston Texas 77030
Site #305 Houston Texas 77079
Site #459 Katy Texas 77494
Site #433 San Antonio Texas 78125
Site #212 San Antonio Texas 78229
Site #434 Waco Texas 78125
Site #441 West Jordan Utah 84088
Site #463 Manassas Virginia 20110
Site #226 Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06108219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06108219 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →